The authors – CM Wittich, CM Burkle, and WL Lanier – offer a concise review of the topic of off-label drug use including its definition, prevalence, and implications for drug safety. ربح مال حقيقي من النت The article format addresses 10 common questions...
Four proposals that address drug advertising and marketing issues, which have not been widely discussed, may be incorporated into the final health care reform bill. 1) Of most concern to the pharmaceutical industry is a proposal to eliminate the tax deduction for...
Allergan, the maker of Botox, is suing the federal goverment by asserting that marketing restrictions prevent the company from communicating practical medical information — like patient selection criteria or optimal dosing patterns — to doctors that could reduce the...
